NCT06600321
Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT06600321
Title A Study to Evaluate ALN-BCAT in Patients With Hepatocellular Carcinoma
Recruitment Recruiting
Gender both
Phase Phase I
Variant Requirements No
Sponsors Alnylam Pharmaceuticals
Indications
Therapies
Age Groups: senior | adult
Covered Countries USA | ITA

Facility Status City State Zip Country Details
Clinical Trial Site RECRUITING Phoenix Arizona 85054 United States Details
Clinical Trial Site RECRUITING Los Angeles California 90033 United States Details
Clinical Trial Site RECRUITING San Diego California 92093 United States Details
Clinical Trial Site RECRUITING Jacksonville Florida 32224 United States Details
Clinical Trial Site RECRUITING Atlanta Georgia 30322 United States Details
Clinical Trial Site RECRUITING Chicago Illinois 60637 United States Details
Clinical Trial Site RECRUITING Ann Arbor Michigan 48109 United States Details
Clinical Trial Site RECRUITING Rochester Minnesota 55905 United States Details
Clinical Trial Site RECRUITING New York New York 10029 United States Details
Clinical Trial Site RECRUITING New York New York 10032 United States Details
Clinical Trial Site RECRUITING Cleveland Ohio 44106 United States Details
Clinical Trial Site RECRUITING Pittsburgh Pennsylvania 15232 United States Details
Clinical Trial Site RECRUITING Dallas Texas 75390 United States Details
Clinical Trial Site RECRUITING Houston Texas 77030 United States Details
Clinical Trial Site RECRUITING San Antonio Texas 78229 United States Details
Clinical Trial Site RECRUITING Richmond Virginia 23298 United States Details
Clinical Trial Site RECRUITING Verona Italy Details
Clinical Trial Site RECRUITING Busan South Korea Details
Clinical Trial Site RECRUITING Seongnam-si South Korea Details
Clinical Trial Site RECRUITING Seoul South Korea Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field